Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes: Immunotherapy
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes: Immunotherapy using peptides has been successful for some patients with allergies, but has not yet been deployed in autoimmune diseases, which may involve greater safety risks. Alhadj Ali et al ....
Source: sciencemag.org
Is Exenatide a Treatment for Parkinson’s Disease? Athauda, Dilan. Wyse, Richard. Brundin, Patrik. Foltynie, Thomas. Journal
Is Exenatide a Treatment for Parkinson’s Disease? Athauda, Dilan. Wyse, Richard. Brundin, Patrik. Foltynie, Thomas. Journal of Parkinson's Disease. "There is growing interest in the use of glucagon-like peptide-1
agonists as treatments for Parkinson’s disease following the recent
publication...
Source: iospress.com
The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents Vallöf,
The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents Vallöf, Daniel. Maccioni, Paola. Colombo, Giancarlo. Mandrapa, Minja. Jörnulf, Julia Winsa. Egecioglu, Emil. Engel, Jörgen A.. Jerlhag, Elisabet. Addiction Biology.
Source: wiley.com
RSS feed